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Enterohemorrhagic E. coli (EHEC) is a food-borne pathogen that causes disease ranging
from uncomplicated diarrhea to life-threatening hemolytic uremic syndrome (HUS) and
nervous system complications. Shiga toxin 2 (Stx2) is the major virulence factor of
EHEC and is critical for development of HUS. The genes encoding Stx2 are carried by
lambdoid bacteriophages and the toxin production is tightly linked to the production of
phages during lytic cycle. It has previously been suggested that commensal E. coli could
amplify the production of Stx2-phages and contribute to the severity of disease. In this
study we examined the susceptibility of commensal E. coli strains to the Stx2-converting
phage φ734, isolated from a highly virulent EHEC O103:H25 (NIPH-11060424). Among
38 commensal E. coli strains from healthy children below 5 years, 15 were lysogenized by
the φ734 phage, whereas lytic infection was not observed. Three of the commensal E. coli
φ734 lysogens were tested for stability, and appeared stable and retained the phage for at
least 10 cultural passages. When induced to enter lytic cycle by H2O2 treatment, 8 out of
13 commensal lysogens produced more φ734 phages than NIPH-11060424. Strikingly, five
of them even spontaneously (non-induced) produced higher levels of phage than the H2O2
induced NIPH-11060424. An especially high frequency of HUS (60%) was seen among
children infected by NIPH-11060424 during the outbreak in 2006. Based on our findings, a
high Stx2 production by commensal E. coli lysogens cannot be ruled out as a contributor
to the high frequency of HUS during this outbreak.
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INTRODUCTION
Enterohemorrhagic Escherichia coli (EHEC) causes disease with
manifestations ranging from mild diarrhea to severe illness
comprising hemorrhagic colitis (HC) (Riley et al., 1983) and
hemolytic uremic syndrome (HUS) (Karmali et al., 1983, 1985).
The E. coli serotype O157:H7, which caused the first described
EHEC outbreak in 1982 (Riley et al., 1983) is so far the
best described EHEC serotype. However, non-O157:H7 serotype
strains have been implicated in a number of outbreaks and spo-
radic cases of HC and HUS (Luna-Gierke et al., 2014). In Europe,
E. coli serotypes such as O103:H25 and O104:H4 have caused
severe outbreaks (Schimmer et al., 2008; Beutin and Martin,
2012).
EHEC strains possess a range of colonization and virulence
factors that facilitate infection and contribute to development
of disease. Shiga toxin (Stx) is recognized as one of the main
virulence factors in enterohemorrhagic disease caused by E. coli
and all EHEC strains produce one or both of the Shiga toxins
Stx1 and Stx2 (Scotland et al., 1985). Stx2 has been shown to be
far more potent (as quantified by LD50 in mice) than Stx1 and
patients infected with the latter are much less likely to develop
serious illness than those infected by the former (Tesh et al.,
1993; Friedrich et al., 2002). After being produced in the large
intestine the Stx toxin passes through the epithelial cells and
is disseminated via the blood stream to the target organs. Stx
binds specifically and with high-affinity to the glycosphingolipid
receptor globotriaosylceramide (Gb3) which is highly expressed
in kidney cells (Jacewicz et al., 1986; Hughes et al., 2000; Okuda
et al., 2006; Shimizu et al., 2007; Shin et al., 2009). After bind-
ing to the receptor, Stx is translocated into the cytosol where it
causes cell damage by inhibiting protein synthesis (Sandvig and
van Deurs, 2000). The Stx induced cell damage appears to be cen-
tral in the pathogenic events leading to HUS and occasionally
chronic kidney disease (Obrig, 2010; Obrig and Karpman, 2012).
About 15 years ago, several E. coli and Shigella strains were
lysogenized with labeled Stx2 phages in vitro (Schmidt et al.,
1999; James et al., 2001), and successful in vivo transduction
experiments with Stx derivative phages have also been reported
(Acheson et al., 1998; Toth et al., 2003). When a bacterial cell
is infected by an Stx-encoding phage, two different pathways
are possible (Allison, 2007). During lytic infection, the phage
DNA exists as a separate molecule within the cell and utilizes
the host machinery to express its genes and to produce large
amounts of new phage particles until the host cell bursts. The
other outcome is lysogenic infection, where the phage genome
is integrated into the chromosome as a prophage, and is repli-
cated along with the host genome. The phage can remain in the
lysogenic state as long as the phage genes are repressed. It has
been shown in several studies that the stx2 genes are controlled
by the phage late gene promoter, and that phage production is
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tightly linked to production of Stx toxin (Neely and Friedman,
1998; Unkmeir and Schmidt, 2000; Zhang et al., 2000; Wagner
et al., 2002). Upon induction, the prophage can switch from the
lysogenic state to the lytic cycle, accompanied by production of
Stx and new phage particles (Herold et al., 2004; Waldor and
Friedman, 2005). Several physical and chemical agents may act
as prophage-inducing agents and all share the ability to activate
the bacterial SOS response, mainly due to DNA damage (Kimmitt
et al., 2000; Erill et al., 2007). Mitomycin C has often been used as
prophage-inducing agent in studies of EHEC, however, H2O2 has
been shown to be an effective prophage-inducer (Los´ et al., 2009,
2010) and its presence in the gut may also increase Stx production
(Wagner et al., 2001).
It has been reported that phages present in the gastrointestinal
tract tend to enter the lysogenic pathway more often than the lytic
pathway (Reyes et al., 2012). Factors like the number of infecting
phages per bacterial cell and cell size prior to infection have been
shown to influence whether the host will lyse or become lysogenic
(St-Pierre and Endy, 2008). However, the mechanisms that deter-
mine the cell fate following phage-infection are complex and not
fully understood.
Previous studies have shown that Stx-phages display a diverse
host range, and also infect commensal E. coli (Wagner et al., 1999;
Muniesa et al., 2003; Gamage et al., 2004). Gamage et al. (2004)
demonstrated that commensal E. coli infected with Stx2 phages
from E. coli O157:H7 were able to produce Stx2 and possibly
increase the pathogenic potential of EHEC during infection. The
contribution of commensal E. coli flora to Stx production was also
demonstrated in a mouse model infected with E. coli O157:H7,
where Stx was more commonly detected in mice colonized with
E. coli sensitive to the Stx-phage than mice colonized with E. coli
resistant to the Stx phage (Gamage et al., 2006). Children are
particularly susceptible to EHEC infections and development of
HUS (Tarr et al., 2005; Gyles, 2007). In 2006, Norway experi-
enced a foodborne EHEC outbreak comprising 17 cases where all
patients, except one (an adult aged 18), were children. The out-
break had an HUS frequency of 60%, which is extremely high,
and all HUS patients were less than 9 years old (Schimmer et al.,
2008). Due to the high HUS frequency, the causative strain, E.coli
O103:H25 (NIPH-11060424), was considered to be particularly
virulent (Schimmer et al., 2008). The strain was later shown to be
closely related to the E. coli O104:H4 strain causing a large out-
break in Germany in 2011 (L’ Abée-Lund et al., 2012). However,
the genetic and phenotypic features underlying the extraordi-
nary high virulence of the Norwegian outbreak strain are not yet
known.
In this study, we examine the susceptibility of commensal
E. coli isolates from young children to the Stx2-converting phage
(φ734) from the 2006 Norwegian outbreak strain. We address the
commensal E. coli strains sensitivity for lytic and lysogen infec-
tion and their ability to contribute to φ734 phage production and
thereby Stx2 production.
MATERIALS AND METHODS
BACTERIAL STRAINS AND PHAGES
The bacterial strains used in this study are listed in Table 1
and Supplementary Table 1. The commensal E. coli strains
were isolated from fecal samples from healthy Norwegian chil-
dren below 5 years of age in the years 2009–2014. All strains
tested negative against Test Serum Anti-Coli O 103:K- and Anti-
Coli O157:K- in agglutination tests (SIFIN, Germany). EHEC
O103:H25 NIPH-11060424 is a highly virulent strain which
caused a severe outbreak in Norway in 2006 (Schimmer et al.,
2008; L’ Abée-Lund et al., 2012). The phage infection experiments
in this study were performed using the Stx2-converting phage
φ734 from NIPH-11060424 (L’ Abée-Lund et al., 2012) or the
recombinant version of this phage (Table 1). The recombinant
phage φ734Cm in which stx2A is replaced by the chloram-
phenicol resistance gene (cat) was constructed by Dr. Muniesa,
University of Barcelona, Spain, as described by Serra-Moreno
et al. (2006). E. coli DH5α was used as a propagating strain for
determination of phage concentration. A stable lysogen of the lab-
oratory strain E. coliC600 carryingφ734 (C600:φ734) was created
by infecting E. coli C600 with φ734. The lysogen was identified by
PCR using the stx2 primers listed in Table 2.
PREPARATION OF PHAGE FILTRATES FOR PHAGE INFECTION
EXPERIMENTS
E. coli strains carrying either φ734 or φ734Cm were grown
in Lysogeny broth (LB) to mid-exponential growth phase
Table 1 | E. coli strains and bacteriophages used in the study.
Bacterial strains and
phage
Characteristics References
E. coli LABORATORY STRAINS
C600 K-12 derivate Appleyard, 1954
DH5α K-12 derivate Hanahan, 1985
EHEC STRAINS
NIPH-11060424 Human isolate, Norwegian
outbreak strain 2006,
O103:H25. Possesses the
Stx2-phage φ734 and the
phi-like phage TL-2011b
Schimmer
et al., 2008;
L’ Abée-Lund
et al., 2012
COMMENSAL E. coli ISOLATES
NVH-1034-NVH-1042,
NVH-1064-NVH-1094
L1034-L1042,
L1064-L1094
Child isolates (n = 38)
non-O103/O157
φ734 Cm lysogens of the
commensal E. coli isolates
with corresponding
numbering
This study
RECOMBINANT E. coli STRAINS
NIPH-
11060424:φ734Cm
φ734 Cm lysogen in
NIPH-11060424a
This study
C600:φ734 Cm
C600:φ734
φ734 Cm lysogen in C600a
φ734 lysogen in C600a
This study
This study
BACTERIOPHAGES
φ734 Stx2-converting phage from
NIPH-11060424
(GenBank acc no
JQ011318.1)
Synonyme name is TL-2011c
L’ Abée-Lund
et al., 2012
φ734 Cm φ734stxA::cat This study
aThe strains were stable.
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Table 2 | PCR primers used in the study.
Primers Sequence (5′-3′) References
stx2 forward GCGTTTTGACCATCTTCGT Muniesa and Jofre,
1998
stx2 reverse ACAGGAGCAGTTTCAGACAG Muniesa and Jofre,
1998
cat forward GGGCGAAGAAGTTGTCCATA This study
cat reverse
phi-phage forward
phi-phage reverse
TACACCGTTTTCCATGAGCA
GCGGTCATGAAAACAAACCT
AGGCGGCAGGATTTATCAAG
This study
This study
This study
(OD600 = 0.3–0.5) and then left non-induced or induced by
addition of either Mitomycin C (MMC) (0.5μg/ml) or H2O2
(1.5mM). The cultures were then further incubated overnight
at 37◦C followed by centrifugation for 10min at 4500 rpm
and sterile-filtrated using 0.22μm filters (Millex-GP, Millipore,
Bedford, MA). The phage concentration in the bacteria-free fil-
trate was determined by plaque assay using E. coli DH5α as
a propagating strain. In order to remove any colicins, Trypsin
(Sigma) was added to the phage-filtrate to a final concentration
of 0.1mg/ml followed by 1 h incubation at 37◦C (Gordon and
O’Brien, 2006).
PLAQUE ASSAY
A plaque assay was used to determine the concentration of infec-
tive phage particles in the phage filtrates. A volume of 100μl
of phage filtrate was mixed with 900μl of E. coli DH5α cul-
ture (OD600 = 0.3) containing 10mM CaCl2, and then further
incubated without agitation for 30min. After incubation, the
samples were mixed with 2.5ml 0.7% LB agar and poured onto
LB agar plates containing 10mM CaCl2. The plates were incu-
bated overnight at 37◦C and plaques were counted. The phage
concentration is given as plaque forming units/ml (PFU/ml).
Hybridization of plaques in E. coli DH5α lawn was performed
to confirm that E. coli DH5α was susceptible to φ734 and φ734
Cm (see the Materials and Methods below). The results showed
that 100% of the plaques were positive for the corresponding
probe, either stx2A or cat. Thus, E. coliDH5αwas used to quantify
the number of phages in the phage filtrates.
PLAQUE HYBRIDIZATION
Plaque hybridization was performed according to a standard
procedure (Datz et al., 1996; Sambrook and Russell, 2001)
using Hybond-N+ membranes (Amersham Pharmacia Biotech).
The membranes were hybridized against a DIG labeled PCR
amplified probe (primers shown in Table 2). Labeling of probe
and hybridization were performed using the DIG-High Prime
DNA Labeling and Detection Starter Kit I (Roche Diagnostics,
Mannheim, Germany) according to the manufacturer’s instruc-
tion. The hybridization temperature used for all experiments was
56◦C.
LYTIC PHAGE INFECTION
To test for susceptibility to lytic infection, 5μl of φ734 phage-
filtrate was spotted on LB soft agar plates with 10mM CaCl2,
containing commensal E. coli strains, E. coliC600 or E. coliDH5α.
The concentrations of the φ734 phage-filtrates used in the spot
assay were 106 PFU/ml when propagated on NIPH-11060424 and
109 PFU/ml when propagated on E. coli C600. The LB plates were
incubated overnight at 37◦C. The susceptibility to lytic infec-
tion among the commensal E. coli strains were additionally tested
using the plaque assay where the recipient culture had a cell
density of 1 × 108 CFU/ml (OD600 = 0.3) and the φ734 phage
concentration was either 1 × 108 PFU/ml or 1 × 105 PFU/ml,
giving a multiplicity of infection (MOI) of 1 and 0.001,
respectively.
LYSOGEN INFECTION
The recombinant φ734Cm phage was used to test commensal
E. coli strains for susceptibility to lysogenic infection as described
previously (Schmidt et al., 1999). The commensal E. coli strains
were tested for Cm sensitivity prior to the experiment, and
all strains were found sensitive. Colonies growing on LB plates
containing 25μg/ml of chloramphenicol were considered to be
lysogens. Lysogens from each commensal strain were named by
adding the prefix L to their wildtype number. Phage filtrate from
13 lysogens (Table 3) was prepared to examine their phage pro-
duction by plaque assay using DH5α as a recipient strain. The
stability of the φ734Cm phage containing lysogens was tested by
culturing lysogens in LB without antibiotic selection for 10 pas-
sages. After each passage, dilutions of the cultures were spread
onto LB plates with chloramphenicol to examining the level of
bacteria carrying φ734Cm.
SEMI-QUANTIFICATION OF Stx2 LEVELS BY VTEC-RPLA KIT
A VTEC RPLA-toxin detection kit (Oxoid Limited, Basingstoke,
UK) was used to determine the Stx2 production by NIPH-
11060424 and C600:φ734. The assay was performed according to
the manufacturer’s instruction. The amount of sample in each
test well was reduced 2-fold at each dilution. The Stx2 titer was
defined as the reciprocal of the highest dilution causing latex
agglutination.
WESTERN BLOT
Proteins were separated by electrophoresis using the NuPAGE
Novex Bis-Tris gel systems (Invitrogen) and SeeBlue Plus2
Pre-Stained Standard (Invitrogen) as molecular weight marker.
After electrophoresis, the proteins were transferred to a
PVDF membrane (Millipore) according to standard protocols
(Harlow and Lane, 1988). Stx2 in culture supernatants was
detected using monoclonal antibodies against Stx2 (STX2-11E10,
TOXIN TECHNOLOGY, INC., Sarasota, FL) diluted 1:1000.
Biotin-conjugated anti-mouse antibodies from goat (Amersham
Biosciences) were used as secondary antibodies (1:3000). A com-
plex of streptavidin (Bio-Rad) and biotinylated alkaline phos-
phatase (Bio-Rad) was used at a dilution of 1:3000 prior to devel-
opment with nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl
phosphate (Bio-Rad).
STATISTICAL ANALYSIS
Student’s t-test was used to determine significant differences
between groups. A P ≤ 0.05 was considered significant.
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Table 3 | Susceptibility of 38 commensal E. coli strains to lysogenic
infection by the φ734 Cm phage.
E. coli
isolates
φ734 Cm from
NIPH-
11060424: φ734
Cm
MOI 0.005
φ734 Cm
from
C600: φ734
Cm
MOI 0.005
φ734 Cm
from
C600: φ734
Cm
MOI 0.5a
φ734 Cm
from
NVH-1090:
φ734 Cm
MOI 0.5
NVH-1034 −/− −/− −/− −/−
NVH-1036 −/− −/− −/− −/−
NVH-1037 −/− −/− 40/20 30/50
NVH-1038 −/− −/− −/− −/−
NVH-1039 −/− −/− −/− −/−
NVH-1040 −/− −/− −/− −/−
NVH-1041 −/− −/− −/− −/−
NVH-1042 −/− −/− −/− −/−
NVH-1064 −/− 200/10 10/90 300/200
NVH-1065 −/− −/10 200/600 20/1000
NVH-1066 −/− 20/− 200/30 30/20
NVG-1067 −/− −/− 200/10 40/100
NVH-1068 −/− −/− −/− −/−
NVH-1069 −/− −/− −/− −/−
NVH-1070 −/− −/− −/− −/−
NVH-1071 −/− −/− −/− −/−
NVH-1072 −/− −/− −/− −/−
NVH-1073 −/− −/− −/− −/−
NVH-1074 −/− −/− −/− −/−
NVH-1075 −/− −/− −/− 500/20
NVH-1076 −/− −/− −/− −/−
NVH-1077 30/100 −/− 1200/400 30/700
NVH-1078 2000/100 500/2000 10000/8000 3000/8000
NVH-1079 −/− −/− −/− −/−
NVH-1080 −/− −/− −/− −/−
NVH-1081 −/− −/− 10/50 30/20
NVH-1083 −/− −/− −/− −/−
NVH-1084 −/− −/− 30/30 −/−
NVH-1085 −/− −/− −/− 30/200
NVH-1086 −/− 70/− 50/300 100/20
NVH-1087 −/− −/− −/− −/−
NVH-1088 −/− 10000/50000 10000/10000 8000/9000
NVH-1089 −/− −/− −/− −/−
NVH-1090 40/200 100/400 4000/3000 3000/2000
NVH-1091 −/− −/− −/− −/−
NVH-1092 −/− −/− −/− −/−
NVH-1093 −/− −/− 60/40 30/80
NVH-1094 −/− −/− −/− −
The phage was propagated on three different strains (the original outbreak strain
NIPH-11060424, the laboratory E. coli strain C600 and the commensal E. coli
strain NVH1090), and two different concentrations of phages (MOI 0.005 and
MOI 0.5) were used. The results are presented as the number of lysogens/ml.
Two replicates were performed for all conditions.
−, no lysogens detected.
alysogens made under this condition were selected for further examination of
phage production (Figure 2).
RESULTS
SUSCEPTIBILITY OF COMMENSAL E. COLI STRAINS TO LYTIC
INFECTION BY THE Stx2-CONVERTING PHAGE φ734
Thirty-eight commensal E. coli strains were tested for suscep-
tibility to lytic infection by φ734 or φ734 Cm propagated on
either in EHEC NIPH-11060424 or on the laboratory strain
E. coli C600. None of the commensal E. coli strains were sus-
ceptible to lytic infection by any of the two phages propagated
on NIPH-11060424 or E. coli C600 at any of the tested con-
centrations. Previous studies have shown that NIPH-11060424
carries a phi-like phage (TL-2011b) in addition to the Stx2 phage
(L’ Abée-Lund et al., 2012). This phi-like phage is 53% identi-
cal to bacteriophage V10, a temperate phage that specifically
infects E. coli of serogroupO157:H7 (Perry et al., 2009). TL-2011b
was shown by spot assay and following hybridization using a phi-
phage specific probe to infect E. coli of serogroup O103:H25,
while none of the commensal strains tested were susceptible
for lytic infection by this phage (Supplementary Table 2). This
indicates that phage TL-2011b is serotype specific.
SUSCEPTIBILITY OF COMMENSAL E. COLI STRAINS TO LYSOGENIC
INFECTION BY THE Stx2-CONVERTING PHAGE φ734 Cm
A total of 15 out of 38 (39%) commensal E. coli isolates were sus-
ceptible to lysogenic infection by φ734Cm (Table 3). The number
of lysogenic cells recovered varied considerably, from 10CFU/ml
to 104 CFU/ml, between the different isolates. Two of the tested
isolates (E. coli NVH-1078 and E. coli NVH-1088) seemed par-
ticularly susceptible to the φ734Cm phage. The bacterial host in
which the phage was produced also influenced the lysogenicity, as
8% (3/38) of the commensal isolates were susceptible to lysogenic
infection by φ734 Cm propagated on NIPH-11060424 while 18%
(7/38) was susceptible to φ734Cm propagated on C600 when the
multiplicity of infection were the same (MOI of 0.005) (Table 3).
Within isolates, the number of lysogens increased with increas-
ing phage concentration. The number of strains susceptible to
φ734 Cm propagated on C600 increased from 18 to 34% (13/38)
when the MOI was increased from 0.005 to 0.5 (Table 3). When
the commensal isolates were infected with φ734 Cm, propagated
on the commensal lysogenic E. coli strain 1090 at an MOI of 0.5,
the number of strains susceptible to lysogenic infection increased
to 39% (15/38) (Table 3).
The level of Cm resistant colonies remained constant during all
cultural passages of the three lysogens (L1078, L1088, and L1090)
that were tested for stability (Figure 1). This shows that φ734Cm
was stably maintained in the commensal hosts.
PHAGE PRODUCTION BY φ734 Cm LYSOGENS UNDER NON-INDUCED
CONDITIONS AND FOLLOWING TREATMENT WITH MMC OR H2O2
The 13 commensal E. coli isolates that were susceptible to
lysogenic infection by φ734Cm propagated on E. coli C600
were selected for further studies (Table 3). These isolates were
tested for phage production during spontaneous (non-induced)
prophage induction and after induction with mitomycin C
(MMC) or H2O2 (Figure 2). There was no difference in phage
production between NIPH-11060424 carrying the original φ734
phage and NIPH-11060424 carrying φ734 Cm. Twelve out of 13
commensal lysogens (L1037, L1064, L1066, L1067, L1077, L1078,
L1081, L1084, L1086, L1088, L1090, and L1093) produced signif-
icantly more phages than NIPH-11060424 under one or more of
the tested conditions. The remaining commensal lysogen (L1065)
produced less Stx2-phages compared to NIPH-11060424. The dif-
ferences between non-induced and induced phage production
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FIGURE 1 | Stability of the commensal E. coli lysogens L1078, L1088, and L1090 during 10 cultural passages in LB broth without chloramphenicol.
After each passage, the bacterial cultures were examined for loss of prophage by determining the number of Cm resistant colonies (CFU/ml).
FIGURE 2 | Bar chart showing Stx2-phage production by
NIPH-11060424, NIPH-11060424:φ734Cm, C600:φ734Cm and 13
commensal E. coli φ734Cm lysogens under non-induced, MMC
induced or H2O2 induced conditions. The error bars represent the
standard error of the mean (SEM) of three independent experiments.
An asterisk indicates statistical significant difference (P < 0.05) in
phage titer from lysogen compared to corresponding phage titer from
NIPH-11060424.
(either by MMC or H2O2) were less than 2 log for all lysogens
except L1084, which showed one of the highest MMC induced
phage productions (109 phages/ml). The non-induced culture of
NIPH-11060424:φ734Cm produced about 2 log less phages than
the MMC or H2O2 induced cultures, which produced approx-
imately equal numbers of phages. All the commensal E. coli
lysogens produced more than 104 phages/ml without induction,
and L1081 and L1090 produced nearly as much as 108 phages/ml
in the non-induced cultures (Figure 2). Three lysogens (L1065,
L 1067, and L1086) produced either equal amounts or more
phages in the non-induced cultures than in the MMC induced
cultures. These lysogens also showed 1–2 log greater phage pro-
duction after induction with H2O2 than with MMC. Prior to
the experiments, all the commensal E. coli strains were tested for
the ability to produce phages after MMC induction by testing
the culture filtrates in plaque assay (data not shown). Three of
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the commensal stains (NVH-1064, NVH-1077, and NVH-1086)
carried MMC inducible phages naturally, of which none were of
Stx type. The level of phage production in these strains was neg-
ligible (<103 PFU/ml) compared to the phage production after
φ734Cm infection (>105). Furthermore, the naturally carried
phages formed larger plaques compared to the characteristic pin-
point plaques formed by the Stx2-phages (results not shown)
which made them easy to exclude when counting plaques formed
by φ734.
PHAGE PRODUCTION AND Stx2 EXPRESSION BY E. COLI C600:φ734
While the production of phages was approximately 3 log higher
in C600:φ734 than in NIPH-11060424 after MMC induction
(Figure 3A), the Stx2 titer indicated that Stx2 production was
40 times higher in E. coli C600:φ734 than in NIPH-11060424
(Figure 3B).Western blot analysis of the phage filtrates confirmed
the high Stx2 production by C600:φ734 (Figure 3C).
DISCUSSION
Children are usually more susceptible to EHEC infections and
development of HUS than other groups. While some individu-
als exposed to the bacteria become ill others carry the bacteria
asymptomatically, and the reason for this is still unknown. There
is increasing evidence that commensal E. coli strains infected with
Stx2-converting phages can contribute to Stx production in the
intestine, and thereby increase the pathogenicity during EHEC
infection (Gamage et al., 2003, 2004, 2006; Toth et al., 2003;
Cornick et al., 2006). In this report, we provide results which
suggest that some commensal E. coli have the potential to be
significant producers of Stx and could have contributed to the
extraordinary pathogenicity of strain NIPH-11060424 during the
Norwegian 2006 EHEC outbreak.
We showed that 39% of commensal E. coli isolates from chil-
dren were susceptible to lysogenic infection by a chloramphenicol
resistant derivative of φ734. No lytic infection of the commensal
E. coli isolates was observed which is consistent with the low rate
of lytic infection by Stx2-encoding phages observed in other stud-
ies (Schmidt et al., 1999; James et al., 2001; Gamage et al., 2004;
Reyes et al., 2012). The lysogenic infection rate observed here is
comparable to the rates reported in other studies (Gamage et al.,
2004). Gamage et al. (2004) found that 35% of E. coli isolates
were susceptible to lysogenic infection by the Stx2-converting
phage W933. The E. coli isolates tested in that study were of
both clinical and non-clinical origin from animals and humans,
and were therefore distinct from our study population. Recently,
Tozzoli et al. (2014) showed that E. coli isolates representing
the main E. coli pathogroups [enterotoxigenic E. coli (ETEC),
enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC),
enteroaggregative E. coli (EAggEC) and extraintestinal pathogenic
E. coli (ExPEC)] were susceptible to infection by Stx2- phages.
However, in contrast to the commensal E. coli isolates studied
here, the pathogenic E. coli strains were only able to carry the
Stx2-phages transiently (Tozzoli et al., 2014).
In accordance with other studies, we observed that an
increased MOI resulted in an increased formation of lysogens
(Zeng and Golding, 2011). However, we also observed that the
strain used for φ734Cm phage production influenced the sus-
ceptibility of the recipient strain to lysogenic infection. When
φ734Cm was produced in either E. coli strain C600 or L1090 it
seemed to tolerate a broader host range compared to when it was
produced in NIPH-11060424 (Table 3).
Phage production by strains NIPH-11060424 and NIPH-
11060424:φ734Cm was very similar under all tested conditions
(Figure 2), indicating that replacing stx2A with the chloram-
phenicol resistance gene (cat) did not influence the behavior of
the phage. The selective marker was convenient in the phage
experiments, as it made retrieval of lysogens more feasible, but,
the recombinant phage was of course unsuitable in experiments
for Stx production. Unfortunately, due to the relatively low infec-
tion rate, we were not able to isolate a commensal E.coli strain
lysogenized by the wild-type φ734 phage. However, we were able
to retrieve the φ734 phage in E. coli C600 (C600:φ734). This
FIGURE 3 | Phage production and Stx2 expression by NIPH-11060424
and E. coli C600: φ734 after MMC induction. (A) Phage production
measured as plaque forming units. (B) Stx2 titer measured by reverse
passive latex agglutination. (C) Stx2 production visualized by Western blot.
The arrow indicates the Stx2A band. The error bars represent the standard
error of the mean (SEM) of three independent experiments. An asterisk
indicates statistical significant difference (P < 0.05) in phage production and
Stx2 expression between C600:φ734 and NIPH-11060424.
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lysogen enabled determination of Stx2 production in another
genetic background than the original EHEC outbreak strain.
Under the same conditions, E. coli C600:φ734 produced about
1000 times more Stx2-converting phage than the original EHEC
outbreak strain, and about 40 times more Stx2 (Figure 3). Stx2
measurements could not be done in the commensal E. coli lyso-
gens, however, based on the close linkage between phage produc-
tion and toxin synthesis (Neely and Friedman, 1998; Unkmeir and
Schmidt, 2000; Zhang et al., 2000; Wagner et al., 2002) we assume
that the number of phage produced in these lysogens will mirror
the amount of Stx2 that would have been produced by the native
Stx2-converting phage. A similar discrepancy between increased
phage-production compared to increased Stx2 production has
been shown earlier by Zhang et al. (2000), where ciprofloxacin
induction of an O157:H7 strain resulted a 1000 fold increase in
phage production while the Stx2 production only increased 58
fold.
The laboratory strain E. coli C600 lysogenized with φ734Cm
produced as much as 109 PFU/ml under non-induced conditions,
which was the highest level of phage production observed during
this study (Figure 2). Phage-production in the commensal E. coli
φ734 Cm lysogens ranged from 104 to nearly 108 PFU/ml under
both induced and non-induced conditions. This means that some
commensal E. coli produced a considerably higher amount of
Stx phage than NIPH-11060424, and also higher levels than
EHEC O157:H7 EDL933, which produced about 106 PFU/ml
under identical non-induced conditions (Imamovic andMuniesa,
2012). The reason why different E. coli strains lysogenized by
an identical phage, produce different amounts of phage is not
known. However, the amount of phages produced is most prob-
ably dependent on the genetic background of the host strain e.g.,
the regulation of the SOS response and the phage repressor system
in each strain will have an impact on phage production.
Since the Stx-prophage induction is closely linked to activation
of the bacterial SOS-response and expression of host-encoded
RecA protein (Fuchs et al., 1999; Kimmitt et al., 2000), the SOS-
response inducing agent MMC is frequently used to activate the
phage- and Stx production in EHEC (Fuchs et al., 1999; Schmidt
et al., 1999; Muniesa et al., 2004). However, H2O2 may represent
a more natural inducing agent, as it is produced in the gut as part
of the innate immune response (Wagner et al., 2001). Five of the
commensal E. coli φ734Cm lysogens demonstrated higher phage
production after H2O2 induction than after MMC induction.
The levels of phage production in the non-commensal isolates
NIPH-11060424, NIPH-11060424:φ734 Cm and C600:φ734 Cm
were similar after H2O2 and MMC induction. The strong induc-
ing capability by H2O2 seen in the commensal E. coli lysogens
may have implications for disease, as H2O2 release occurs during
in vivo EHEC infection (Wagner et al., 2001). Surprisingly, we also
observed high production of phage in some of the lysogens under
non-induced conditions. Five of the commensal E. coli φ734
Cm lysogens produced a higher amount of phage non-induced,
FIGURE 4 | Suggested model of commensal E. coli contribution to
Stx2 production in the intestinal tract. The Stx2-phage φ734 are
produced by its EHEC host and infect susceptible commensal E. coli
strains lysogenically. The commensal E. coli φ734 lysogens enter the
lytic cycle either spontaneously or after exposure to inducing agents
present in the intestinal environment. The commensal lysogens produce
phages at a high frequency leading to a concomitant increase in Stx2
production.
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than NIPH-11060424 did under either H2O2 or MMC induced
conditions.
The observed lack of lytic infection by the φ734 phage
in the commensal E. coli isolates contrasts the high level of
non-induced phage production in the corresponding lysogens.
However, together these results indicate that commensal E. coli
strains might contribute to Stx2 production through first becom-
ing lysogenized and then subsequently enter the lytic cycle at a
high frequency (Figure 4). It has previously been reported that
spontaneous induction occurs more readily in Stx-phages than
in other lambdoid phages (Livny and Friedman, 2004; Aertsen
et al., 2005; Shimizu et al., 2009). However, spontaneous induc-
tion to the extent observed in this study has, to our knowledge,
not previously been reported.
Since efficient Stx production only occurs after prophage
induction followed by lysis and death of the host cell, one may
expect that EHEC carrying these phages will eventually die out.
Recently, Los´ et al. suggested that prophages are induced at a
low frequency in the gut which does not compromise the persis-
tence of the EHEC population (Los´ et al., 2012). There are various
repressor systems that interfere with phage production in strains
carrying several prophages (Burz et al., 1994; Serra-Moreno et al.,
2008). The lower production of phages by NIPH-11060424 com-
pared to strain C600:φ734 and several of the commensal E. coli
lysogens may result from the presence of repressor systems orig-
inating from other prophages in the genome of NIPH-11060424.
These repressor systems may act to keep a balance between the
lysogenic and lytic infection and thereby benefit the survival of
the EHEC population.
In conclusion, we observed that a high proportion of com-
mensal E. coli is susceptible to infection by φ734 Cm and that
some isolates were infected at a higher frequency than others. The
φ734 Cm phage infected the commensal E. coli isolates only via
the lysogenic pathway. Some of the commensal E. coli lysogens
produced considerably higher amounts of phage particles than
EHEC NIPH-11060424. These lysogens would also likely have
produced high levels of Stx2 if they were lysogenized with the
original Stx2-converting phage φ734 as modeled in Figure 4. This
study supports the hypothesis that Stx2-converting phages are
able to infect commensal E. coli strains, and thereby enhance Stx2
production during EHEC infection. Together our data strongly
endorse that Stx2-converting phages released from EHEC in the
gut can lysogenize commensal E. coli and turn them into effective
Stx producers and thus enhance the pathogenicity of the EHEC
infection. Therefore, it would be interesting to examine commen-
sal E. coli isolates from asymptomatic EHEC carriers and from
EHEC triggered HUS patients for Stx phage susceptibility and for
the presence of lysogenic Stx-phages.
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